| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12016-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26403-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26531-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26599-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26626-50ul | |||
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (IDEC-131 (Toralizumab)) - Chimeric [NBP3-12016] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of IDEC-131 (Toralizumab) (NBP3-12016) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12016, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-IDEC-131-Toralizumab-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12016-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (IDEC-131 (Toralizumab)) - Chimeric [NBP3-12016] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of IDEC-131 (Toralizumab) (NBP3-12016) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12016, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Western Blot: c-Myc [p Thr58, p Ser62] Antibody (4E9) [NBP3-26403] - Positive Western Blot detected in HepG2 whole cell lysate (treated with EGF or not).<br /> All lanes: c-Myc [p Thr58, p Ser62] Antibody at 0.99ug/ml.<br /> Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution.<br /> Predicted band size: 57 KDa<br /> Observed band size: 57 KDa<br />](http://images.novusbio.com/fullsize/nbp3-26403_rabbit-c-myc-p-thr-58-p-ser-62-mab-4e9-28220241152519.jpg "<b>Biological Strategies Validation. </b>Western Blot: c-Myc [p Thr58, p Ser62] Antibody (4E9) [NBP3-26403] - Positive Western Blot detected in HepG2 whole cell lysate (treated with EGF or not).<br /> All lanes: c-Myc [p Thr58, p Ser62] Antibody at 0.99ug/ml.<br /> Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution.<br /> Predicted band size: 57 KDa<br /> Observed band size: 57 KDa<br />")
![Immunohistochemistry: SOD2/Mn-SOD [ac Lys68] Antibody (23G5) [NBP3-26531] - Image of SOD2/Mn-SOD [ac Lys68] Antibody (23G5) diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.69% DAB.](http://images.novusbio.com/fullsize/nbp3-26531_rabbit-sod2-mn-sod-ac-lys-68-mab-23g5-262202414471582.jpg "Immunohistochemistry: SOD2/Mn-SOD [ac Lys68] Antibody (23G5) [NBP3-26531] - Image of SOD2/Mn-SOD [ac Lys68] Antibody (23G5) diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.69% DAB.")
![Human p53 ELISA Kit [NBP1-91257] - Data for Human p53 Platinum ELISA](http://images.novusbio.com/fullsize/Human-p53-ELISA-Kit-NBP1-91257-img0001.jpg "Human p53 ELISA Kit [NBP1-91257] - Data for Human p53 Platinum ELISA")
![Immunocytochemistry/Immunofluorescence: GluR2/3 Antibody (4C3) [NBP3-15223] - Immunofluorescence staining of MCF-7 cells with GluR2/3 antibody at 1:56, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-congugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/GluR2-3-Antibody-4C3-Immunocytochemistry-Immunofluorescence-NBP3-15223-img0001.jpg "Immunocytochemistry/Immunofluorescence: GluR2/3 Antibody (4C3) [NBP3-15223] - Immunofluorescence staining of MCF-7 cells with GluR2/3 antibody at 1:56, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-congugated Goat Anti-Rabbit IgG (H+L).")
![Immunocytochemistry/Immunofluorescence: ErbB3/Her3 Antibody (6F6) [NBP3-26599] - Staining of MCF7 Cells with ErbB3/Her3 Antibody (6F6) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. Nuclear DNA was labeled in blue with DAPI. The secondary antibody was FITC-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26599_rabbit-erbb3-her3-mab-6f6-282202412475111.jpg "Immunocytochemistry/Immunofluorescence: ErbB3/Her3 Antibody (6F6) [NBP3-26599] - Staining of MCF7 Cells with ErbB3/Her3 Antibody (6F6) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. Nuclear DNA was labeled in blue with DAPI. The secondary antibody was FITC-conjugated Goat Anti-Rabbit IgG (H+L).")
![ELISA: Bcl-2 ELISA Kit [NBP1-91188] - Standard curve](http://images.novusbio.com/fullsize/Bcl-2-ELISA-Kit-ELISA-NBP1-91188-img0001.jpg "ELISA: Bcl-2 ELISA Kit [NBP1-91188] - Standard curve")
![Immunohistochemistry: DDX6 Antibody (6D8) [NBP3-26626] - Image of DDX6 Antibody (6D8) diluted at 1:100 and staining in paraffin-embedded human brain tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.](http://images.novusbio.com/fullsize/nbp3-26626_rabbit-ddx6-mab-6d8-262202414471540.jpg "Immunohistochemistry: DDX6 Antibody (6D8) [NBP3-26626] - Image of DDX6 Antibody (6D8) diluted at 1:100 and staining in paraffin-embedded human brain tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.")